• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 93 of 100
157934085
FinanceTeva in talks to buy Allergan’s generic drug business
By ReutersJuly 26, 2015
World’s first malaria vaccine, from GlaxoSmithKline, wins approval from EU
FeaturesWorld’s first malaria vaccine, from GlaxoSmithKline, wins approval from EU
By Laura LorenzettiJuly 24, 2015
Just like with regular sports, eSports athletes will be tested for drugs
TechJust like with regular sports, eSports athletes will be tested for drugs
By Chris MorrisJuly 24, 2015
Fight against Daesh in Turkey's Syrian borderline
FeaturesISIS and drug sales — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithJuly 24, 2015
Cancer research laboratory
LeadershipDoctors say cancer drug costs are out of control
By Claire GrodenJuly 23, 2015
Apple aftershock and a new frontier for Alzheimer’s treatments–5 things to know today
FeaturesApple aftershock and a new frontier for Alzheimer’s treatments–5 things to know today
By Laura Lorenzetti and Geoffrey SmithJuly 22, 2015
peanuts
TechHow one startup plans to end the EpiPen monopoly
By Corinne IozzioJuly 21, 2015
Apple Worldwide Developers Conference Opens In San Francisco
FeaturesApple, Greek banks, and earnings — 5 things to know this week
By Tom Huddleston Jr.July 19, 2015
Pharma M&A boom rolls on: now Celgene’s buying Receptos
TechPharma M&A boom rolls on: now Celgene’s buying Receptos
By Geoffrey SmithJuly 15, 2015
Vida Health and AstraZeneca launch new app for post-heart attack recovery
TechVida Health and AstraZeneca launch new app for post-heart attack recovery
By Laura LorenzettiJuly 14, 2015
Meet BioBot, the ‘MakerBot of biology’
TechMeet BioBot, the ‘MakerBot of biology’
By Andrew ZaleskiJuly 13, 2015
Novartis senses a blockbuster after FDA approves its new heart drug
TechNovartis senses a blockbuster after FDA approves its new heart drug
By Geoffrey SmithJuly 9, 2015
CVS Health leaving U.S. Chamber of Commerce over smoking spat
RetailCVS Health leaving U.S. Chamber of Commerce over smoking spat
By Phil WahbaJuly 8, 2015
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
FinanceIreland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By Tom Huddleston Jr.July 7, 2015
186815051
TechDespite regulatory troubles, DNA testing firm 23andMe raises more money
By Kia KokalitchevaJuly 2, 2015
1...
  • 91
  • 92
  • 93
  • 94
  • 95
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Politics
You're probably safe from the Hantavirus outbreak, but here's what you absolutely must not do, experts sayplaceholder alt text
By Catherina GioinoMay 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.